Analystreport

RedHill Biopharma Ltd. (NASDAQ: RDHL) had its "buy" rating re-affirmed by analysts at HC Wainwright.

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations